FDA Inspection 969536 — New York Blood Center Enterprises

New York Blood Center Enterprises — FEI 3011940303

The FDA completed an inspection of New York Blood Center Enterprises on May 6, 2016 in Massapequa, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
May 6, 2016
Fiscal Year
2016
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Massapequa, NY (United States)